July 18, 2017

MADISON, WI – July 18, 2017 – Invenra today announced a collaboration with Merck, known as MSD outside the United States and Canada, to discover fully human therapeutic antibodies against an unnamed target of interest to Merck.  Financial details of...

Please reload

PRESS RELEASES

Invenra Announces Expansion of Collaboration with Exelixis

October 31, 2019

1/1
Please reload

Featured
Please reload

Archive
 

CONFERENCE ATTENDANCE

 

World Bispecific Antibody Summit

09.17.2019

Waltham, MA

Advances in Immuno-Oncology USA Congress

10.08.2019

San Diego, CA

Bryan Glaser, Vice President - Business Development, is a guest speaker.

Festival of Biologics 2019

10.15.2019

Basel, Switzerland

SITC 2019

11.06.2019

National Harbor, Maryland

PEGS Europe

11.18.2019

Lisbon, Portugal

Mandar Bawadekar, Senior Scientist - Immunology, is a guest speaker.

Antibody Engineering & Therapeutics

12.09.2019

San Diego, CA

Jonathan Davis, Head of Innovation, is a guest speaker.

Please reload

Invenra®

505 South Rosa Road; Suite 235, Madison, WI 53719       info@invenra.com  |   608.441.8319

connect with us
  • Twitter - Black Circle
  • LinkedIn - Black Circle

© 2018 Invenra, Inc. All Rights Reserved.